David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$880M |
| 3 |
Boeing
BA
|
+$850M |
| 4 |
Eli Lilly
LLY
|
+$689M |
| 5 |
Tesla
TSLA
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$964M |
| 2 |
Apple
AAPL
|
+$606M |
| 3 |
Workday
WDAY
|
+$520M |
| 4 |
Palantir
PLTR
|
+$514M |
| 5 |
Spotify
SPOT
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.54% |
| 2 | Consumer Discretionary | 8.87% |
| 3 | Healthcare | 8.21% |
| 4 | Financials | 5.68% |
| 5 | Industrials | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3751
GCM Grosvenor
GCMG
$823M
| $297K | ﹤0.01% |
+24,227
| New | +$288K |
|
3752
PUT
Legend Biotech
LEGN
$4.19B
| $296K | ﹤0.01% |
+9,100
| New | +$377K |
|
3753
Wheaton Precious Metals
WPM
$74.1B
| $296K | ﹤0.01% |
5,259
+659
| +14% | +$40.8K |
|
3754
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.85B
| $296K | ﹤0.01% |
7,105
-1,456
| -17% | -$62.3K |
|
3755
PUT
Charles River Laboratories
CRL
$14.2B
| $295K | ﹤0.01% |
+1,600
| New | +$308K |
|
|
NOA
3756
North American Construction
NOA
$361M
| $295K | ﹤0.01% |
+13,700
| New | +$268K |
|
3757
First Trust NASDAQ Technology Dividend Index Fund
TDIV
$4.32B
| $295K | ﹤0.01% |
+3,761
| New | +$301K |
|
3758
Tencent Music
TME
$14.5B
| $294K | ﹤0.01% |
25,938
-318,888
| -92% | -$3.78M |
|
3759
PUT
QuidelOrtho
QDEL
$1.02B
| $294K | ﹤0.01% |
6,600
-19,500
| -75% | -$798K |
|
3760
PUT
Transocean
RIG
$6.41B
| $294K | ﹤0.01% |
78,400
| – | – |
|
3761
Opendoor
OPEN
$3.45B
| $294K | ﹤0.01% |
189,719
-327,843
| -63% | -$594K |
|
3762
Home BancShares
HOMB
$5.97B
| $293K | ﹤0.01% |
10,356
-32,249
| -76% | -$931K |
|
3763
Ryman Hospitality Properties
RHP
$9.13B
| $293K | ﹤0.01% |
2,808
-28,276
| -91% | -$3.15M |
|
3764
Northern Trust STOXX Global Broad Infrastructure ETF
NFRA
$3.05B
| $292K | ﹤0.01% |
+5,386
| New | +$310K |
|
3765
HCI Group
HCI
$2.3B
| $291K | ﹤0.01% |
2,500
-15,381
| -86% | -$1.75M |
|
3766
CALL
Ternium
TX
$10.8B
| $291K | ﹤0.01% |
+10,000
| New | +$335K |
|
|
3767
PUT
Ternium
TX
$10.8B
| $291K | ﹤0.01% |
10,000
-45,200
| -82% | -$1.51M |
|
3768
Johnson Controls International
JCI
$85.9B
| $290K | ﹤0.01% |
3,679
-21,582
| -85% | -$1.73M |
|
3769
Sutro Biopharma
STRO
$358M
| $290K | ﹤0.01% |
15,768
-997
| -6% | -$30.4K |
|
3770
Riskified
RSKD
$782M
| $289K | ﹤0.01% |
61,089
-62,768
| -51% | -$291K |
|
3771
CALL
Texas Roadhouse
TXRH
$13.3B
| $289K | ﹤0.01% |
1,600
-35,100
| -96% | -$6.61M |
|
|
GRAL
3772
PUT
GRAIL Inc
GRAL
$3.65B
| $288K | ﹤0.01% |
16,160
-528
| -3% | -$8.59K |
|
3773
iShares US Healthcare Providers ETF
IHF
$1.23B
| $287K | ﹤0.01% |
+5,973
| New | +$315K |
|
3774
First Trust S&P REIT Index Fund
FRI
$200M
| $287K | ﹤0.01% |
+10,469
| New | +$303K |
|
3775
PUT
Schrodinger
SDGR
$1.49B
| $285K | ﹤0.01% |
14,800
-36,100
| -71% | -$701K |
|
Similar funds
David Shaw's Q4 2024 Portfolio in Review
As of Q4 2024, David Shaw held 5,079 positions worth $136B, up 17% from $116B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw deployed $10.6B of net new capital in Q4 2024, opening 591 new positions and adding to 1,620 existing holdings. Its largest new stake was Lam Research: 3,525,438 shares worth $255M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $964M trimmed.
- David Shaw's largest Q4 2024 buy was Lam Research: 3,525,438 shares worth $255M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $3.7B increase.
- David Shaw's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $964M.
- David Shaw fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $81.4M.
- David Shaw's ten largest holdings make up 11% of its $136B portfolio in Q4 2024.
- David Shaw opened 591 new positions and closed 731 in Q4 2024.
- David Shaw's portfolio value rose 17% quarter-over-quarter to $136B.
Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.